Zoledronic acid

Results: 198



#Item
21Radiology / Osteoporosis / Bone density / Aromatase inhibitor / Peripheral quantitative computed tomography / Denosumab / Zoledronic acid / Osteopenia / Breast cancer treatment / Medicine / Ribbon symbolism / Dual-energy X-ray absorptiometry

Public Summary Document Application 1313 – Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2015-04-15 22:13:38
22[removed]   2013  Osteoporosis  GP  Update   mee6ng   M  Kassim  Javaid   Academic  Rheumatology    

[removed]   2013  Osteoporosis  GP  Update   mee6ng   M  Kassim  Javaid   Academic  Rheumatology    

Add to Reading List

Source URL: www.ndorms.ox.ac.uk

Language: English - Date: 2013-07-09 07:03:23
231 ACLASTA zoledronic acid NAME OF THE MEDICINE

1 ACLASTA zoledronic acid NAME OF THE MEDICINE

Add to Reading List

Source URL: gp2u.com.au

Language: English - Date: 2013-08-31 02:43:58
241st Edition[removed]Medicine Medical guide Pharmacological therapy is recommended for men and women with osteoporosis, including

1st Edition[removed]Medicine Medical guide Pharmacological therapy is recommended for men and women with osteoporosis, including

Add to Reading List

Source URL: arthritis.sslsvc.com

Language: English - Date: 2013-10-29 08:58:04
25Pharmaceutical Benefits Scheme / Pharmacology / Quality use of medicines / Ustekinumab / Psoriasis / Zoledronic acid / Renal cell carcinoma / Alternative medicine / Denosumab / Monoclonal antibodies / Medicine / Health

The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 81st meeting on 5 June[removed]DUSC is a national focus of excellence in collecting, analysing and interpreting da

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-13 00:20:02
26Drug Utilisation Sub-Committee Outcome Statement 5 June 2014 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 81st meeting on 5 June[removed]DUSC is a national foc

Drug Utilisation Sub-Committee Outcome Statement 5 June 2014 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 81st meeting on 5 June[removed]DUSC is a national foc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-13 00:20:02
27Appendix - Research Dental Health Services Completed Research and Development Evaluation Evaluation of Pulpotomies in Deciduous Teeth. A total of ~600 children have been followed for

Appendix - Research Dental Health Services Completed Research and Development Evaluation Evaluation of Pulpotomies in Deciduous Teeth. A total of ~600 children have been followed for

Add to Reading List

Source URL: www.health.wa.gov.au

Language: English - Date: 2004-12-12 22:47:55
28Report to the ANZBMS Council on travel undertaken with funding from the Christine and T

Report to the ANZBMS Council on travel undertaken with funding from the Christine and T

Add to Reading List

Source URL: www.anzbms.org.au

Language: English - Date: 2015-02-22 22:41:40
29Asian J Gerontol Geriatr 2009; 4: 79–82 Bisphosphonate-associated osteonecrosis of the jaw in a Chinese rheumatoid arthritis patient

Asian J Gerontol Geriatr 2009; 4: 79–82 Bisphosphonate-associated osteonecrosis of the jaw in a Chinese rheumatoid arthritis patient

Add to Reading List

Source URL: ajgg.org

Language: English - Date: 2014-04-10 22:27:27
30PATIENT INFORMATION ON BISPHOSPHONATES (INTRAVENOUS / IV) (Examples of brand names: Aclasta, Aredia)

PATIENT INFORMATION ON BISPHOSPHONATES (INTRAVENOUS / IV) (Examples of brand names: Aclasta, Aredia)

Add to Reading List

Source URL: www.rheumatology.org.au

Language: English - Date: 2014-03-20 02:10:37